Trial
NCT02749227
Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
—
Condition
Pituitary Tumor
Intervention
Pasireotide LAR
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-27